Variant genotypes ofCDKN1AandCDKN1Bare associated with an increased risk of breast cancer in Chinese women
Open Access
- 27 June 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 119 (9) , 2173-2178
- https://doi.org/10.1002/ijc.22094
Abstract
P21Cip1 and p27Kip1 are cyclin‐dependent kinase inhibitors, which can arrest cell proliferation and serve as tumor suppressors. Reduced protein expression of p21Cip1 and p27Kip1 was frequently observed in a subset of cancers, including breast cancer. In this study, we hypothesized that genetic variants in CDKN1A (encode for p21Cip1) and CDKN1B (encode for p27Kip1) may modulate the risk of breast cancer. To test this hypothesis, we evaluated the associations of the polymorphisms of Ser31Arg and C+20T in CDKN1A and C−79T and Gly109Val in CDKN1B, as well as their combinations, with breast cancer risk in a case‐control study of 368 breast cancer cases and 467 cancer‐free controls in a Chinese population. We found that a significantly increased risk of breast cancer was associated with the variant genotypes of CDKN1B C−79T [adjusted OR = 1.43 (95% CI = 1.03−1.98) for −79TC/TT], compared with the −79CC genotype, but no associations were observed for other variant genotypes. However, the combined variant genotypes of the 4 loci were associated with a significantly increased breast cancer risk (adjusted OR = 1.49, 95% CI = 1.11−2.01 among subjects carrying 3 or more variant alleles), especially among premenopausal women (adjusted OR= 2.30, 95% CI = 1.45−3.66). Furthermore, in premenopausal women, this significant association remained unchanged, after including other individual risk factors in the multivariate logistic regression model, suggesting an independent role of CDKN1A and CDKN1B variants in breast cancer risk. Although the exact biological mechanism remains to be explored, our findings suggest possible involvement of CDKN1A and CDKN1B variants in the etiology of breast cancer. Further large and functional studies are needed to confirm our findings.Keywords
Funding Information
- National Key Basic Research Program (2002CB512908)
- Department of Education of China Key Grants for Universities and Colleges (705023)
- Jiangsu Natural Science Foundation (BK2004145)
- Postdoctoral Science Foundation of China (2004035218)
This publication has 37 references indexed in Scilit:
- p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor αMolecular and Cellular Biology, 2005
- Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesisOncogene, 1999
- CDK inhibitors: positive and negative regulators of G1-phase progressionGenes & Development, 1999
- Cancer Cell CyclesScience, 1996
- A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 -Deficient MiceCell, 1996
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Cell, 1996
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996
- Principles of CDK regulationNature, 1995
- Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signalsCell, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993